Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap5.35B
Market cap5.35B
Price-Earnings ratio38.58
Price-Earnings ratio38.58
Dividend yield—
Dividend yield—
Average volume235.86K
Average volume235.86K
High today$189.96
High today$189.96
Low today$183.26
Low today$183.26
Open price$187.90
Open price$187.90
Volume257.30K
Volume257.30K
52 Week high$207.84
52 Week high$207.84
52 Week low$122.80
52 Week low$122.80
KRYS News
TipRanks 2d
Krystal Biotech’s Promising Lung Cancer Study: A Potential Game-Changer?Krystal Biotech, Inc. ((KRYS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
TipRanks 2d
Krystal Biotech’s KB407 Study: A Promising Step for Cystic Fibrosis TreatmentKrystal Biotech, Inc. ((KRYS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
TipRanks 3d
Krystal Biotech Advances DEB Research with New Observational StudyKrystal Biotech, Inc. ((KRYS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.